![Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2152265017319432-gr1.jpg)
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig1_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9019050/bin/41408_2022_662_Tab1_HTML.jpg)
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma | Haematologica
![Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse](https://www.frontiersin.org/files/Articles/786451/fonc-12-786451-HTML-r1/image_m/fonc-12-786451-t001.jpg)
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
![t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.leu.2403091/MediaObjects/41375_2003_Article_BF2403091_Fig1_HTML.gif)
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia
![IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis | HTML IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis | HTML](https://www.mdpi.com/ijms/ijms-22-07470/article_deploy/html/images/ijms-22-07470-g002.png)
IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis | HTML
![Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41385-022-00503-0/MediaObjects/41385_2022_503_Fig1_HTML.png)
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology
![Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22804-x/MediaObjects/41467_2021_22804_Fig1_HTML.png)
Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications
![Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram](https://www.researchgate.net/publication/7053433/figure/fig6/AS:280657927393280@1443925472049/Survival-by-light-chain-type-for-IgG-and-IgA-myeloma-stratified-by-the-presence-or.png)
Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram
![The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/95c2f91a-7269-4785-9561-f3cd80995d58/bjh_4867_f2.gif)
The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant - Chang - 2004 - British Journal of Haematology - Wiley Online Library
![Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.159/MediaObjects/41375_2013_Article_BFleu2012159_Fig1_HTML.jpg)
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
![Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma](https://www.mdpi.com/biomedicines/biomedicines-10-00209/article_deploy/html/images/biomedicines-10-00209-g001.png)
Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma
![Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01180-x/MediaObjects/41375_2021_1180_Fig1_HTML.png)
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
![Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download Sergio Giralt defends the PRO position To Maintain or Not to Maintain The Answer is Yes And Lenalidomide is the Right Choice. - ppt download](https://images.slideplayer.com/26/8597741/slides/slide_4.jpg)